コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 her forms of epilepsy associated with severe intellectual disability.
2 sion program that is aberrantly expressed in intellectual disability.
3 Syndrome (FXS), the most prevalent inherited intellectual disability.
4 renia, and 63% versus 24% of individuals had intellectual disability.
5 X syndrome (FXS), the most common inherited intellectual disability.
6 n factor mutated in families with hereditary intellectual disability.
7 a (Dyrk1a) and mutations in both genes cause intellectual disability.
8 tein-truncating variants presented with mild intellectual disability.
9 o CTCF, including schizophrenia, autism, and intellectual disability.
10 ome (DS) is the most common genetic cause of intellectual disability.
11 h an overlapping phenotype of mild to severe intellectual disability.
12 tributes to trisomy-21/Down-syndrome-related intellectual disability.
13 ypical behaviours and high co-morbidity with intellectual disability.
14 X syndrome is rare but a prominent cause of intellectual disability.
15 (NDDs) such as autism spectrum disorder and intellectual disability.
16 s, including Fragile X syndrome, autism, and intellectual disability.
17 e result in autosomal recessive nonsyndromic intellectual disability.
18 as-yet poorly defined syndrome that includes intellectual disability.
19 t the C11orf46(R236H) mutant associated with intellectual disability.
20 es, and 1% of the population are affected by intellectual disability.
21 ng for the loss-of-function mutation causing intellectual disability.
22 early-life seizures, autistic behaviors, and intellectual disability.
23 ependent sodium channels cause severe autism/intellectual disability.
24 ficiency of OGT could contribute to X-linked intellectual disability.
25 ith unexplained childhood-onset epilepsy and intellectual disability.
26 CNVs and genes in patients with epilepsy and intellectual disability.
27 ase family and is linked to both obesity and intellectual disability.
28 nderstand the aetiology of Zbtb11-associated intellectual disability.
29 interactions in the pathogenesis of ASD and intellectual disability.
30 ntly described as a cause of severe X-linked intellectual disability.
31 -onset peripheral neuropathy with or without intellectual disability.
32 of Slack channels, resulting in epilepsy and intellectual disability.
33 isorders including often severe epilepsy and intellectual disability.
34 associated with autism spectrum disorder and intellectual disability.
35 that altered lipid metabolism contributes to intellectual disability.
36 own syndrome (DS) is the most common form of intellectual disability.
37 ll adhesion molecule NLGN4X result in ASD or intellectual disability.
38 cephaly, autism spectrum disorder (ASD), and intellectual disability.
39 llitus, sensorineural hearing loss, and mild intellectual disability.
40 ders characterized by epilepsy with comorbid intellectual disability.
41 coexisting conditions, including autism and intellectual disability.
42 and neurodevelopmental defects are linked to intellectual disability.
43 activity recently identified in humans with intellectual disability.
44 mosome-linked disease associated with severe intellectual disabilities.
45 genes, including some involved in autism and intellectual disabilities.
46 FMRP leads to sensory dysfunction and severe intellectual disabilities.
48 les from mothers of children with autism and intellectual disability; (2) an inflammatory cytokine mi
50 ith de novo heterozygous mutations displayed intellectual disability, ambulation deficits, severe lan
51 ged 18 years or older, with mild to moderate intellectual disabilities and clinically significant dep
54 es including Autism Spectrum Disorder (ASD), intellectual disabilities and Phelan-McDermid syndrome.
55 -53.01; P = 0.001) for eyes of children with intellectual disability and 21.93 (95% CI, 2.95-162.80;
56 iduals, with male-to-female ratios of 2:1 in intellectual disability and 4:1 in autism spectrum disor
57 al phenotypic overlap, including features of intellectual disability and abnormal growth, underscorin
58 MRI to scan autistic males (n = 19) without intellectual disability and age- and IQ-matched typicall
60 ral brain disorders, including the inherited intellectual disability and autism spectrum disorder, fr
61 ing protein 1A (CC2D1A), which is mutated in intellectual disability and autism spectrum disorder, we
62 iquitinating enzyme previously implicated in intellectual disability and autism spectrum disorder.
63 aptic disorder, and a disease model for both intellectual disability and autism spectrum disorder.
64 in individuals with Pitt-Hopkins syndrome-an intellectual disability and autism spectrum disorder.
65 ild (E1483K) or severe epilepsy (R1872W), or intellectual disability and autism without epilepsy (R16
66 the fourth mutation, A1622D, causing severe intellectual disability and autism without epilepsy, we
67 ontrast, the R1620L mutation associated with intellectual disability and autism-but not epilepsy-redu
68 hared and specific biological information of intellectual disability and CHD by conducting systems bi
69 ild to moderate neurodevelopmental delay and intellectual disability and conclude that variants putat
70 show brain abnormalities with microcephaly, intellectual disability and delayed gross motor and spee
72 ts in RALA were also described as a cause of intellectual disability and developmental delay, indicat
73 heterozygous patient diagnosed with profound intellectual disability and epilepsy and systematically
74 ntribute to this proposed monogenic cause of intellectual disability and epilepsy remain unresolved.
75 four children from independent families with intellectual disability and epilepsy, revealing bi-allel
79 were recently reported to be associated with intellectual disability and epilepsy; the functional eff
80 enriched for syndromic causes of autism and intellectual disability and for genes that in later deve
81 on of trisomy 21, we have learned much about intellectual disability and genetic risk factors for con
82 individuals had developmental delays and/or intellectual disability and impairments in speech and la
83 yndrome is the most common form of inherited intellectual disability and is caused by a deficiency of
85 alencephaly, a subgroup with higher rates of intellectual disability and larger cerebral volumes, may
86 yseal dysplasia, sensorineural hearing loss, intellectual disability and Leber congenital amaurosis (
87 is case-control study, we used data from the Intellectual Disability and Mental Health: Assessing the
88 t variants in KDM4B are associated with GDD/ intellectual disability and neuroanatomical defects.
89 elative short stature and variable degree of intellectual disability and neurological features as the
90 rological phenotype, with high prevalence of intellectual disability and optic nerve atrophy/hypoplas
92 lepsy, cerebral palsy, feeding difficulties, intellectual disability and other neurological and behav
93 d NETO genes in individuals with Scz, ASD or intellectual disability and population controls; perform
94 ofound hypotonia and muscle weakness, severe intellectual disability and progressive cerebellar atrop
95 s confers risk for schizophrenia, autism and intellectual disability and provide new genetic and phar
97 culminating in a recognizable syndrome with intellectual disability and signature brain and congenit
99 est that SHANK3 deficiency may predispose to intellectual disability and socio-communicative impairme
101 e (FXS) is the most common form of inherited intellectual disability and the leading monogenetic caus
102 yndrome (FXS) is the leading known inherited intellectual disability and the most common genetic caus
103 cause of a neurodevelopmental disorder with intellectual disability and variable brain anomalies.
104 ilies with the common phenotypic features of intellectual disability and/or global developmental dela
105 orders, including autism spectrum disorders, intellectual disabilities, and schizophrenia, are linked
106 disorder (CDD) is characterized by epilepsy, intellectual disability, and autistic features, and CDKL
108 a few individuals with developmental delay, intellectual disability, and brain malformations have mi
110 th disruptive mutations present with autism, intellectual disability, and delayed language and motor
113 four children who share developmental delay, intellectual disability, and mild facial and digital mor
115 ral sclerosis, Huntington disease, dementia, intellectual disability, and other brain diseases from 1
116 associated with cancer-related pathologies, intellectual disability, and schizophrenia are increasin
118 al phalanges with small finger and toenails, intellectual disability, and seizures; this condition ov
119 ons, seizures, global developmental delay or intellectual disability, and severe sleep disturbance.
121 phthalmoplegia, cardiomyopathy, nonsyndromic intellectual disability, apoptosis, and the Warburg effe
122 eafness, onychodystrophy, osteodystrophy and intellectual disability are associated with a spectrum o
123 ia (Scz), autism spectrum disorder (ASD) and intellectual disability are common complex neurodevelopm
125 genetic variations found in individuals with intellectual disability are the causes for the phenotype
127 rphisms, short stature, developmental delay, intellectual disability as well as cardiac hypertrophy.
128 e, Dravet syndrome and infantile spasms with intellectual disability as well as relatively mild epile
129 e epilepsy, autism spectrum disorder, and/or intellectual disability, as well as other systemic manif
130 ntal symptoms including developmental delay, intellectual disability, ataxia, axial hypotonia, cerebr
131 such as developmental delay, mild-to-severe intellectual disability, ataxia, epilepsy, and behaviora
132 and is characterized by developmental delay, intellectual disability, ataxia, seizures and a happy af
133 ther neurodevelopmental comorbid conditions (intellectual disabilities, autism spectrum disorders, ep
134 le to neurodevelopmental disorders including intellectual disability, autism spectrum disorder, and a
135 phenotypes that include developmental delay, intellectual disability, autism spectrum disorder, and b
136 t major neurodevelopmental disorders such as intellectual disability, autism spectrum disorder, atten
137 sk for neuropsychiatric phenotypes including intellectual disability, autism spectrum disorder, gener
138 The most common features in our cohort were intellectual disability, autism spectrum disorder, seizu
139 nked to neurodevelopmental disorders such as intellectual disability, autism, and schizophrenia.
140 ts (CNVs) have been robustly associated with intellectual disability, autism, and schizophrenia.
141 with neurodevelopmental disorders, including intellectual disability, autism, schizophrenia, and bipo
142 clinical features, including mild to severe intellectual disability, autism, severe speech and motor
143 C6 gene in patients with a syndromic form of intellectual disability [Beaulieu-Boycott-Innes syndrome
144 characterized by hypotonia, mild to moderate intellectual disability, behavioral disorders, and varia
145 n inborn error of metabolism presenting with intellectual disability, behavioral disturbances and epi
146 autistic behavior, language impairment, and intellectual disability, but feeding difficulties and ga
147 isk factors for autism spectrum disorder and intellectual disability, but it has not been reported if
148 ility of Rac1 inhibitors in the treatment of intellectual disability caused by Cc2d1a mutations in hu
149 icantly enriched in patients with autism and intellectual disability compared to healthy controls and
150 ther genes carrying rare mutations linked to intellectual disability contribute to ADHD risk through
151 , and wide mouth, developmental delay and/or intellectual disability, corpus callosum agenesis or hyp
153 ght also underlie developmental delay and/or intellectual disability (DD and/or ID) disease phenotype
154 m of clinical features including ichthyosis, intellectual disability, decreased fertility, and short
155 VTs or indices, in clinical populations with intellectual disability, degenerative brain disease, bra
156 ected individuals include variable levels of intellectual disability, delayed speech and motor milest
157 ion variants in DYRK1A exhibit microcephaly, intellectual disability, developmental delay and/or cong
158 ts are the cause of a recessive disease with intellectual disability, developmental delay, and short
159 variants in DDX6 in probands presenting with intellectual disability, developmental delay, and simila
160 er characterized with a spectrum of central (intellectual disability, developmental delay, motor impa
161 guineous families with probands that exhibit intellectual disability, developmental delay, short stat
162 neurodevelopmental condition associated with intellectual disability/developmental delay, autism spec
163 the SMARCB1 (BAF47) subunit, which cause the intellectual disability disorder Coffin-Siris syndrome (
164 that are associated with human cancer or the intellectual disability disorder Sifrim-Hitz-Weiss syndr
168 tal lethal motor neuron disease and X-linked intellectual disability disorders, yet its role in proce
169 with autism spectrum disorder comorbid with intellectual disability, distinctive facial features, an
171 fox1, an RNA binding protein associated with intellectual disability, epilepsy and autism, increases
172 lapping, syndromic forms of NDDs with severe intellectual disability, epilepsy and microcephaly.
173 often associated with microcephaly, profound intellectual disability, epilepsy, and impaired motor ab
174 eurodevelopmental disorders that manifest as intellectual disability, epilepsy, autism, or schizophre
176 IFA (cleft lip, cataract, tooth abnormality, intellectual disability, facial dysmorphism, attention-d
177 individuals with developmental delay and/or intellectual disability, facial dysmorphisms, and congen
179 certained autism spectrum disorder (ASD) and intellectual disabilities from records of additional sup
181 in a diagnostic gene panel of 396 autosomal intellectual disability genes were tested for associatio
182 erozygous mutations have been shown to cause intellectual disability, growth deficiency, and dysmorph
183 phenotype consisting of developmental delay, intellectual disability, growth retardation, microcephal
184 ation of 15q11.2-13.1) cases associated with intellectual disability, highlight RNA-editing dysregula
185 uals with autism spectrum disorder (ASD) and intellectual disability; however, its clinical significa
186 ndrome (FXS) is characteristically displayed intellectual disability, hyperactivity, anxiety, and abn
187 lobal motor development delay, speech delay, intellectual disability, hypotonia and a history of seiz
188 ls include global developmental delay and/or intellectual disability, hypotonia, cerebellar ataxia, c
189 ndividuals present with developmental delay, intellectual disability, hypotonia, feeding difficulties
190 senting heterozygous dominant de novo autism-intellectual disabilities (ID) causing mutations is acti
192 tations in the NMD factor gene, UPF3B, cause intellectual disability (ID) and are strongly associated
193 thylases KDM5A, KDM5B, or KDM5C are found in intellectual disability (ID) and autism spectrum disorde
194 with neurodevelopmental diseases, including intellectual disability (ID) and autism spectrum disorde
195 pe subunits have recently been implicated in intellectual disability (ID) and developmental delay (DD
196 y identified in nine individuals with severe intellectual disability (ID) and disruptive behavior.
197 merged as a collectively common etiology for intellectual disability (ID) and growth disruption.
198 oning; a number of affected individuals have intellectual disability (ID) and markedly impaired basic
199 RIA2 mutations in 28 unrelated patients with intellectual disability (ID) and neurodevelopmental abno
200 icase DDX3X account for 1%-3% of unexplained intellectual disability (ID) cases in females and are as
201 e contribution of de novo variants in severe intellectual disability (ID) has been extensively studie
203 ene defects are the leading genetic cause of intellectual disability (ID) in countries with frequent
206 efficacy for ADHD in children with comorbid intellectual disability (ID) or borderline intellectual
207 ree affected parents with varying degrees of intellectual disability (ID) or developmental delay (DD)
208 families with multigenerational nonsyndromic intellectual disability (ID) segregating with a recurren
209 ted the orthologs of 286 genes implicated in intellectual disability (ID) with or without comorbid au
210 r rates of global developmental delay (GDD), intellectual disability (ID), and motor delay in individ
211 ociated with autism spectrum disorder (ASD), intellectual disability (ID), and schizophrenia (SZ).
212 ficantly different in their association with intellectual disability (ID), consistent with the existe
214 -q13.3 locus with a common facial phenotype, intellectual disability (ID), distinctive behavioral fea
215 e facial features with gingival enlargement, intellectual disability (ID), hypertrichosis, and hypopl
216 neurodevelopmental disorder characterized by intellectual disability (ID), motor and speech delay, au
219 autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are therefore cla
222 tified 28 rare or novel CNVs associated with intellectual disability in 22 additional obese subjects
223 to the OGT catalytic domain lead to X-linked intellectual disability in boys, but it is not clear if
224 ty disorder (ADHD) frequently co-occurs with intellectual disability in children, and may further com
227 in the SYNGAP1 gene have been shown to cause intellectual disability in humans and have been linked t
231 phenotype of thrombocytopenia accompanied by intellectual disability in patients with a de novo heter
232 d significant speech delay (50% non-verbal); intellectual disability in the moderate to severe range;
233 and Rett syndrome (RTT) are associated with intellectual disability, infantile spasms and seizures.
236 tion.SIGNIFICANCE STATEMENT Mild to moderate intellectual disability is a prominent feature of Down s
237 Syndrome (FXS), a common inheritable form of intellectual disability, is known to alter neocortical c
238 ile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic caus
239 neurodevelopmental disorder characterized by intellectual disability, lack of speech, ataxia, EEG abn
240 f severe global developmental delay, current intellectual disability, language delay, cerebellar atro
242 ies of having an IQ in the normal (>/=70) or intellectual disability (<70) range were calculated.
243 s in PAK1 in four unrelated individuals with intellectual disability, macrocephaly and seizures.
244 variants in PAK1 lead to moderate-to-severe intellectual disability, macrocephaly caused by the pres
245 symptoms included neurodevelopmental delay, intellectual disability, macrocephaly, and psychiatric d
246 ly recognizable by the combined phenotype of intellectual disability, macrothrombocytopenia, camptoda
247 ith Takenouchi-Kosaki syndrome revealed that intellectual disability, macrothrombocytopenia, camptoda
248 e role of genetic variation in both genes in intellectual disability may be through different mechani
249 B1 as a genetic etiology in individuals with intellectual disability, microcephaly, and epilepsy.
250 s have a speech delay, and most present with intellectual disability, motor delay, behavioral issues,
251 nts, who present with a clinical spectrum of intellectual disability, motor delay, speech delay, seiz
253 obal developmental delay, severe to profound intellectual disability, muscle weakness and abnormal to
254 for de novo mutations underlying autism and intellectual disability, mutations in the ADNP gene are
256 h ongoing seizure activity in adulthood, (2) intellectual disability of any degree, and (3) no struct
257 had motor and language developmental delay, intellectual disability often associated with early-onse
258 th autism spectrum disorder (autism) without intellectual disability often have normal structural lan
259 n patients with autism spectrum disorder and intellectual disability or developmental disorders to sh
260 ts in NCOR1, NCOR2 or HDAC3 in patients with intellectual disability or neurodevelopmental disorders.
261 esenting with an X-linked syndrome involving intellectual disability, proportionate short stature, mi
265 isk of neuropsychiatric disorders, including intellectual disability, schizophrenia, attention-defici
266 developmental disorder characterized by mild intellectual disability, seizures, behavioral abnormalit
267 xtrapolate the core phenotype, consisting of intellectual disability, short stature, microcephaly, li
268 missense variants associated with autism and intellectual disability.SIGNIFICANCE STATEMENT Here, we
269 families with a consistent phenotype of mild intellectual disability, similar facies, myopathy, and c
270 viduals presenting with microcephaly, severe intellectual disability, simplification of cerebral gyra
271 comprising global developmental delay and/or intellectual disability, subtle facial dysmorphisms, beh
273 se Nicolaides-Baraitser syndrome (NCBRS), an intellectual disability syndrome associated with delayed
274 nyder-Robinson syndrome (SRS) is an X-linked intellectual disability syndrome caused by a loss-of-fun
275 of patients with MEHMO syndrome, an X-linked intellectual disability syndrome, have identified severa
281 ency is a preventable and treatable cause of intellectual disability that should be considered in the
282 f neurological disorders, such as autism and intellectual disability, that are characterized by dendr
283 ions) in 4,789 (0.6%) children, with ASD and intellectual disability the most common combination.
284 ns and exhibiting developmental delay and/or intellectual disability; the individuals are from 17 unr
286 disability (present in 84%) ranged from mild intellectual disability to severe global disability; mov
287 attention deficit hyperactivity disorder and intellectual disability, to later life, such as dementia
288 equencing on 1696 patients with epilepsy and intellectual disability using a gene panel with 480 epil
289 terized by global developmental delay and/or intellectual disability, variable axon pathfinding defec
290 rt of children with autism spectrum disorder/intellectual disability versus healthy controls revealed
291 X syndrome (FXS), a common form of inherited intellectual disabilities with a high risk for ASDs.
292 d clinically recognizable syndromic forms of intellectual disability with contrasting craniofacial dy
293 characterized by global developmental delay, intellectual disability with language deficit, autistic
294 features, especially midface hypoplasia, and intellectual disability with severe expressive language
295 fication factors (site, age at baseline, and intellectual disability), with an additional prespecifie
296 causing intermediate or severe epilepsy, or intellectual disability without epilepsy, respectively)
297 A total of 40 affected males have X-linked intellectual disability (XLID) and variable behavioral a
300 me (FXS), the most common cause of inherited intellectual disability, yet it is unknown how FMRP func